About Allos Therapeutics (NASDAQ:ALTH)
Allos Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of anti-cancer therapeutics. As of December 31, 2011, the Company focused on the development and commercialization of FOLOTYN (pralatrexate injection). FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. FOLOTYN targets the inhibition of dihydrofolate reductase (DHFR), an enzyme critical in the folate pathway, thereby interfering with deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) synthesis and triggering cancer cell death. FOLOTYN can be delivered as a single agent, for which the Company has approval for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), and can be used in combination therapy regimens. On September 5, 2012, Spectrum Pharmaceuticals, Inc. acquired Allos Therapeutics, Inc.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Allos Therapeutics (NASDAQ:ALTH) Frequently Asked Questions
What is Allos Therapeutics' stock symbol?
Allos Therapeutics trades on the NASDAQ under the ticker symbol "ALTH."
Who are some of Allos Therapeutics' key competitors?
Some companies that are related to Allos Therapeutics include Johnson & Johnson (JNJ), Novartis (NVS), UnitedHealth Group (UNH), Pfizer (PFE), AbbVie (ABBV), Roche (ROG), Amgen (AMGN), Bristol-Myers Squibb (BMY), Abbott Laboratories (ABT), Gilead Sciences (GILD), Novo Nordisk A/S (NVO), Sanofi (SNY), GlaxoSmithKline (GSK), Eli Lilly and (LLY), Thermo Fisher Scientific (TMO), AstraZeneca (AZN), Bayer (BAYN) and Sanofi (SAN).
How do I buy Allos Therapeutics stock?
Shares of Allos Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Allos Therapeutics?
Allos Therapeutics' mailing address is 11080 Circle Point Rd Ste 200, WESTMINSTER, CO 80020-2778, United States. The biopharmaceutical company can be reached via phone at +1-303-4266262.
MarketBeat Community Rating for Allos Therapeutics (ALTH)MarketBeat's community ratings are surveys of what our community members think about Allos Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Allos Therapeutics (NASDAQ:ALTH) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Allos Therapeutics (NASDAQ:ALTH) Earnings History and Estimates Chart
Allos Therapeutics (NASDAQ ALTH) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Allos Therapeutics (NASDAQ:ALTH) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Allos Therapeutics (NASDAQ:ALTH)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Allos Therapeutics (NASDAQ ALTH)
No insider trades for this company have been tracked by MarketBeat.com
Allos Therapeutics (NASDAQ ALTH) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Allos Therapeutics (NASDAQ:ALTH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Allos Therapeutics (NASDAQ:ALTH) Income Statement, Balance Sheet and Cash Flow Statement
Allos Therapeutics (NASDAQ ALTH) Stock Chart for Saturday, February, 17, 2018